Axel Bouchon
Directeur Général chez AMLOne UG (haftungsbeschränkt)
Profil
Axel Bouchon, Ph.D., is a biochemist, author and serial entrepreneur in the biotech, consumer and technology industries and is focused on neuroscience and prevention of neurological diseases.
He is fundamentally driven by the question “What makes our brains truly happy?”.
Axel joined ARCH as a Venture Partner in 2021.
He is a Director at Brii Biosciences, Co-founder and Chairman of BrainLuxury, Inc., and Cofounder and CEO of BrainGames Corporation.
Before joining ARCH, Axel was leading the venture activities of LEAPS by Bayer (2015-2019) and Moderna Therapeutics, Inc. (2013-2014), and served as CEO, director and chairman in multiple pharmaceutical and biotechnology companies over the last 15 years.
Axel holds a Ph.D.
in biochemistry, organic chemistry and immunology from the University of Tuebingen, Germany.
Postes actifs de Axel Bouchon
| Sociétés | Poste | Début |
|---|---|---|
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Private Equity Investor | 01/12/2021 |
Brii Biosciences Ltd.
 Brii Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Brii Biosciences Ltd. is a biotechnology company, which engages in the provision of healthcare solutions. It focuses on the development of therapies for infectious diseases such as hepatitis B, COVID-19, human immunodeficiency virus (HIV) infection, multi-drug resistant (MDR) or extensive drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases. The company was founded by Zhi Hong in 2018 and is headquartered in Durham, NC. | Directeur/Membre du Conseil | - |
| Brain Games Corp. | Président | 01/01/2020 |
| AMLOne UG (haftungsbeschränkt) | Directeur Général | 01/07/2016 |
Matter Neuroscience
 Matter Neuroscience Packaged SoftwareTechnology Services Matter Neuroscience is an American company that develops mobile applications for neurological reward systems. The private company was founded by Benjamin Goldhirsh and Axel Bouchon, with Axel Bouchon serving as the CEO since incorporation. | Directeur Général | 01/01/2019 |
Anciens postes connus de Axel Bouchon
| Sociétés | Poste | Fin |
|---|---|---|
BrainLuxury, Inc.
 BrainLuxury, Inc. Pharmaceuticals: OtherHealth Technology BrainLuxury, Inc. is a company that provides natural alternatives for deep sleep and focus, driven by science. The company is based in New York, NY. The company's mission is to nourish the brain to support natural deep sleep, focus, and creativity with no artificial melatonin or stimulants. The company's products, Delta and Gamma, are 100% safe and contain no preservatives, gluten, added sugar, or animal products. BrainLuxury was founded in 2020 by Ivica Djurdjevic, Hermann Schützinger, and Axel Bouchon. Hermann Schützinger has been the CEO since 2020. | Fondateur | 01/01/2023 |
| BRII BIOSCIENCES LIMITED | Directeur/Membre du Conseil | 30/09/2022 |
| BAYER AG | Corporate Officer/Principal | 01/01/2019 |
| MODERNA, INC. | Corporate Officer/Principal | - |
| ░░░░░░░ ░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░ | - |
Formation de Axel Bouchon
| Eberhard Karls Universität Tübingen | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| BAYER AG | Health Technology |
| MODERNA, INC. | Health Technology |
| BRII BIOSCIENCES LIMITED | Commercial Services |
| Entreprise privées | 7 |
|---|---|
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Finance |
Moderne Capital LLC
 Moderne Capital LLC Investment ManagersFinance Moderne Capital LLC (Moderne Ventures) is a venture capital firm founded in 2015 by Constance Freedman. The firm is headquartered in Chicago, Illinois. | Finance |
Brii Biosciences Ltd.
Brii Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Brii Biosciences Ltd. is a biotechnology company, which engages in the provision of healthcare solutions. It focuses on the development of therapies for infectious diseases such as hepatitis B, COVID-19, human immunodeficiency virus (HIV) infection, multi-drug resistant (MDR) or extensive drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases. The company was founded by Zhi Hong in 2018 and is headquartered in Durham, NC. | Health Technology |
| Brain Games Corp. | |
BrainLuxury, Inc.
BrainLuxury, Inc. Pharmaceuticals: OtherHealth Technology BrainLuxury, Inc. is a company that provides natural alternatives for deep sleep and focus, driven by science. The company is based in New York, NY. The company's mission is to nourish the brain to support natural deep sleep, focus, and creativity with no artificial melatonin or stimulants. The company's products, Delta and Gamma, are 100% safe and contain no preservatives, gluten, added sugar, or animal products. BrainLuxury was founded in 2020 by Ivica Djurdjevic, Hermann Schützinger, and Axel Bouchon. Hermann Schützinger has been the CEO since 2020. | Health Technology |
| AMLOne UG (haftungsbeschränkt) | |
Matter Neuroscience
Matter Neuroscience Packaged SoftwareTechnology Services Matter Neuroscience is an American company that develops mobile applications for neurological reward systems. The private company was founded by Benjamin Goldhirsh and Axel Bouchon, with Axel Bouchon serving as the CEO since incorporation. | Technology Services |
